Travere Therapeutics SVP, Chief Accounting Officer Sandra Calvin disposes of $335,983 in common shares - TVTX News | RalliesTravere Therapeutics SVP, Chief Accounting Officer Sandra Calvin disposes of $335,983 in common shares
T
TVTX• Insider share sale and option exercise
- Sandra Calvin, SVP and chief accounting officer, sold 5,375 Travere Therapeutics common shares on Sep. 15, 2026.
- Sales were priced between $62.14 and $63.66 per share.
- She exercised employee stock options for 5,375 shares at $20.46 to $27.5.
- Beneficial ownership ended at 42,353 common shares.
•
